Clinical Trial Update: Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Relapsed/Refractory Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating mitoxantrone hydrochloride liposome injection for relapsed/refractory multiple myeloma is underway with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Mitoxantrone Hydrochloride Liposome Injection (mitoxantrone hydrochloride liposome)

Snippet

Sponsor: Second Affiliated Hospital of Soochow University | Conditions: Relapsed/Refractory Multiple Myeloma | Phase 1, Phase 2 | Status: UNKNOWN